dc.contributor.author | Özmen, Vahit | |
dc.contributor.author | Cabioglu, Neslihan | |
dc.contributor.author | Dinccag, Ahmet | |
dc.contributor.author | Aydıner, Adnan | |
dc.contributor.author | Yavuz, Ekrem | |
dc.contributor.author | Oner, Gizem | |
dc.contributor.author | Önder, Semen | |
dc.contributor.author | Karatay, Huseyin | |
dc.contributor.author | Tükenmez, Mustafa | |
dc.contributor.author | Muslumanoglu, Mahmut | |
dc.contributor.author | Igci, Abdullah | |
dc.date.accessioned | 2021-03-03T15:28:04Z | |
dc.date.available | 2021-03-03T15:28:04Z | |
dc.identifier.citation | Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., Dinccag A., Özmen V., Aydıner A., Yavuz E., et al., "High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.", JOURNAL OF CLINICAL ONCOLOGY, cilt.36, 2018 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_3f221d85-7db8-46bf-83a6-ad8d8db3e884 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/46255 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2018.36.15_suppl.e24136 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy. | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 36 | |
dc.contributor.firstauthorID | 2502886 | |